Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Cryptosporidiosis |
|
|
Clinical Trial: The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea
This study has been completed.
|
Purpose
To examine the efficacy of cow's milk immune globulin in the treatment of diarrhea due to chronic intestinal cryptosporidiosis in patients with AIDS. The secondary end points of the study involve functional improvement which will be determined from nutritional and absorption studies.
| Condition | Treatment or Intervention |
|---|---|
| Cryptosporidiosis HIV Infections | Drug: Cryptosporidium Immune Whey Protein Concentrate (Bovine) |
MedlinePlus related topics: AIDS; Cryptosporidiosis
Study Type: Interventional
Study Design: Treatment
Official Title: Efficacy of Cow's Milk Immune Globulin in the Treatment of Chronic Intestinal Cryptosporidiosis in Patients with AIDS
Eligibility
Ages Eligible for Study: 12 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria
Patients must have:
- Diagnosis of diarrhea associated with intestinal cryptosporidiosis.
Exclusion Criteria
Co-existing Condition: Patients with the following conditions or symptoms are excluded:
- Survival time projected to be < 9 weeks.
- Inability to tolerate any oral intake.
- Known allergy or intolerance to milk products.
- Organic mental syndrome precluding informed consent or following directions.
Patients with the following are excluded:
- Survival time projected to be < 9 weeks.
- Inability to tolerate any oral intake.
- Known allergy or intolerance to milk products.
- Organic mental syndrome precluding informed consent or following directions.
Location Information
New York
Saint Luke's - Roosevelt Hosp Ctr, New York, New York, 10025, United States
More Information
Record last reviewed: November 1999
Last Updated: October 13, 2004
Record first received: November 2, 1999
ClinicalTrials.gov Identifier: NCT00002264
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- ClinicalTrials.gov: Cryptosporidiosis (National Institutes of Health)
- Cryptosporidiosis (National Women's Health Information Center)
email this page
print this page
bookmark this page
feedback on this page
